Investors are unfairly punishing too many stocks as part of a right-pricing of AI-related names. That spells opportunity for ...

Rivian will begin deliveries of its R2 fleet in the second quarter of 2026.

It has a hefty stock portfolio as well. It's built to last, thanks to sound investments, savvy management, and resilient industries. The stock has averaged annual gains of about 20% for decades -- ...

A stock increasing nearly 300% in a single year is remarkable. Bloom Energy 's ( BE +0.39%) stock has exploded and the ...

Despite its fourth-quarter results being pretty solid, the share price of pharmaceutical giant AbbVie ( ABBV +1.71%) fell ...

So, as long as Micron maintains roughly its current P/E ratio and meets or exceeds earnings expectations through 2026, it could potentially exceed $1,200 by the end of August 2026. Even if it doesn't ...

Rhythm Pharmaceuticals ( RYTM +2.05%) is another biotech stock (in this case, a mid-cap stock) that I think could easily ...

Unfortunately, Intel investors will have to be patient with the pace of the chip-maker's turnaround. Tan is frustrated with ...

One of the most successful companies in the healthcare realm is Intuitive Surgical ( ISRG +1.45%), the giant in robotic ...

Perhaps it's no surprise that Nvidia's operating results are the most anticipated of any public company. Though the bulk of ...

With the support of the "Takaichi Trade," Japanese stocks and this iShares ETF could extend their hot starts to 2026.

Cisco shipped its one millionth Silicon One chip during the second quarter. These chips are used in both Cisco hardware and ...